SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-039490
Filing Date
2022-03-29
Accepted
2022-03-29 16:39:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2210732d1_424b5.htm 424B5 9963
2 GRAPHIC tm2210732d1_424b5img001.jpg GRAPHIC 3746
  Complete submission text file 0001104659-22-039490.txt   16361
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-248530 | Film No.: 22781448
SIC: 2834 Pharmaceutical Preparations